~~<i id='6AC556EECD'><strike id='6AC556EECD'><tt id='6AC556EECD'><pre id='6AC556EECD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：entertainment 2025-10-04 04:01:49 - browse：49

JOHNSON & JOHNSON HEADQUARTERS — Daniel Hulshizer/AP

Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease.

To sharpen that focus, R&D chief John Reed told STAT that the company is de-emphasizing two areas that have been mainstays for the drug and medical device giant: infectious disease and vaccines, as well as medicines targeting kidney disease and rare eye conditions.

The disclosures were made in an interview ahead of an investor meeting Reed is leading Tuesday aimed at generating excitement about the company’s research and development efforts.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readout Newsletter: Amgen, Regeneron, BGI Group and more

explore

focus

knowledge

leisure time

hotspot

entertainment

1:29FILE-AsignbearingthecompanylogooutsideaTeslastoreinCherryCreekMallinDenverisseenhereonFeb.9,2019

WSS

The UK government moves asylum

Illinois to ban advertising for guns allegedly marketed to kids and militants

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Moderna hits safety problems in bold bid to reinvent medicine

Wikipedia

focus

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

At least 13 dead in Texas as scorching temps continue

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Hepatitis C has a cure — but many Americans still lack access to it

The CDC's new social media misinformation war

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The CDC's new social media misinformation war

Malaria cases in Florida and Texas: Here’s what you need to know

NYC plans to house migrants on an island in the East River

focus

Texas Medical Board asked to define abortion emergency exception

AstraZeneca stays mum on Medicare drug pricing negotiations

The UK government moves asylum

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

AI gets buy

Why CTE doesn’t keep Americans from enjoying the Super Bowl

knowledge

leisure time

hotspot

entertainment